Saavedra, Adriano E.
HRN: 07-28-00 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/08/2022
CEFTAZIDIME 1GM (VIAL)
12/08/2022
12/14/2022
IVT
1gm
Q8
Copd In Ae, Cap Mr, T/c Bronchiectasis, T/c Ptb Relapse
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes